(Q47996539)

English

Antibody response to allelic variants of 19kDa fragment of MSP-1: recognition of a variant and protection associated with ethnicity in Assam, India.

scientific article published on 28 November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/22133506

Antibody response to allelic variants of 19kDa fragment of MSP-1: recognition of a variant and protection associated with ethnicity in Assam, India. (English)

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/22133506

1 reference

based on heuristic

inferred from title

author name string

Sonia D Lourembam

1

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/22133506

Shashi Baruah

2

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/22133506

language of work or name

0 references

publication date

28 November 2011

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/22133506

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/22133506

30

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/22133506

4

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/22133506

767-773

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/22133506

Human antibodies to the 19kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Sequence heterogeneity of the C-terminal, Cys-rich region of the merozoite surface protein-1 (MSP-1) in field samples of Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Predicted and observed alleles of Plasmodium falciparum merozoite surface protein-1 (MSP-1), a potential malaria vaccine antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

A polymerase chain reaction/ligase detection reaction fluorescent microsphere assay to determine Plasmodium falciparum MSP-119 haplotypes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Antigenic diversity and immune evasion by malaria parasites.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Treatment-seeking for febrile illness in north-east India: an epidemiological study in the malaria endemic zone

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

A randomized trial comparing the efficacy of four treatment regimens for uncomplicated falciparum malaria in Assam state, India.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Temporal and spatial variation in MSP1 clonal composition of Plasmodium falciparum in districts of Assam, Northeast India

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Physiographic and entomologic risk factors of malaria in Assam, India.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

The Plasmodium falciparum merozoite surface protein-1 19 KD antibody response in the Peruvian Amazon predominantly targets the non-allele specific, shared sites of this antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Genomic inferences on peopling of south Asia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Different antibody- and cytokine-mediated responses to Plasmodium falciparum parasite in two sympatric ethnic tribes living in Mali

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Genome-wide linkage analysis of malaria infection intensity and mild disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Antibodies to the conserved C-terminal domain of the Plasmodium falciparum merozoite surface protein 1 and to the merozoite extract and their relationship with in vitro inhibitory antibodies and protection against clinical malaria in a Senegalese vi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

The profile of IgG-antibody response against merozoite surface proteins 1 and 2 in severe Plasmodium falciparum malaria in Eastern Sudan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Differential antibody responses to Plasmodium falciparum merozoite proteins in Malawian children with severe malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Effect of HIV infection on the acute antibody response to malaria antigens in children: an observational study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Acquisition of antibody isotypes against Plasmodium falciparum blood stage antigens in a birth cohort

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

based on heuristic

inferred from DOI database lookup

Short report: IgG1/IgG3 antibody responses to various analogs of recombinant ypfmsp119--a study in immune adults living in areas of Plasmodium falciparum transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.069

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2011.11.069

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/22133506

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/22133506

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47996539&oldid=1382140006"